Evropska unija - slovenščina - EMA (European Medicines Agency)

seqirus s.r.l.  - površinski antigeni virusa influence (hemaglutinin in nevraminidaza) seva: a / turkey / turkey / 1/05 (h5n1), podoben sevu (nibrg-23) - influenza, human; immunization; disease outbreaks - cepiva - aktivna imunizacija proti podtipu h5n1 virusa influence. ta navedba temelji na immunogenicity podatkov iz zdravih predmetov iz 18. leta starosti dalje po uporabi zdravila dva odmerka cepiva, ki vsebujejo/turčija/turkey/1/05 (h5n1) kot sev. aflunov je treba uporabljati v skladu z uradnimi priporočili.

Evropska unija - slovenščina - EMA (European Medicines Agency)

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - cepiva - active immunisation against h5 subtype of influenza a virus.

Evropska unija - slovenščina - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - imunologija za aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - največ tri od naslednjih prečiščeni, inaktivirano slinavke in parkljevke virus sevov: o1 manisa ≥ 6 pd50*; o1 bfs ≥ 6 pd50*; o tajvanu, 3/97 ≥ 6 pd50*; a22 iraku ≥ 6 pd50*; a24 cruzeiro ≥ 6 pd50*; puranji 14/98 ≥ 6 pd50*; azija 1 shamir ≥ 6 pd50*; sat2 savdska arabija ≥ 6 pd50*; * pd50 – 50% zaščitni odmerek goveda, kot je opisano v doktor tehniških znanosti eur. monografija 0063. - imunologija - pigs; cattle; sheep - aktivna imunizacija goveda, ovac in prašičev od 2 tedna starosti proti slinavki in parkljevki za zmanjšanje kliničnih znakov.

Evropska unija - slovenščina - EMA (European Medicines Agency)

eco animal health europe limited - tilvalozin - antiinfectives za sistemsko uporabo, antibacterials za sistemsko uporabo, macrolides - pheasants; chicken; turkeys; pigs - pigstreatment in methaphylaxis prašičev enzootske pljučnica;zdravljenje prašičev proliferative enteropatija (ileitis);zdravljenje in methaphylaxis prašičev driske. chickenstreatment in methaphylaxis dihal bolezni, povezanih z mikroplazma gallisepticum v piščancev. pheasantstreatment dihal bolezni, povezanih z mikroplazma gallisepticum. turkeystreatment dihal bolezni, povezanih z tylvalosin občutljivih sevov ornithobacterium rhinotracheale v puranov.

Evropska unija - slovenščina - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologija za aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - piščanec - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Evropska unija - slovenščina - EMA (European Medicines Agency)

pfizer limited - difloksacin - antibacterials za sistemsko uporabo, antiinfectives za sistemsko zdravljenje - turkeys; dogs; cattle; chicken - piščanci:za zdravljenje kroničnih okužb dihal, ki jih povzročajo občutljivi sevi escherichia coli in mikroplazma gallisepticum. puranov:za zdravljenje kroničnih okužb dihal, ki jih povzročajo občutljivi sevi escherichia coli in mikroplazma gallisepticum. tudi za zdravljenje okužb, ki jih povzročajo pasteurella multocida. psi: za zdravljenje akutnih nezapletenih okužb sečil, ki jih povzročajo escherichia coli ali staphylococcus spp. in površinsko piodermo, ki jo povzroča staphylococcus intermedius. govedo:za zdravljenje govedi, bolezni dihal (dostava vročina, tele pljučnica), ki jih povzročajo eno ali mešane okužbe z pasteurella haemolytica, pasteurella multocida in / ali spp mikroplazma.

Evropska unija - slovenščina - EMA (European Medicines Agency)

seqirus s.r.l.  - površinski antigeni virusa influence, inaktivirani: a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cepiva proti gripi - preprečevanje gripe v uradno prijavljeni pandemični situaciji. pandemije gripe cepiva je treba uporabljati v skladu z uradnimi smernice.

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - površinski antigeni virusa influence (hemaglutinin in nevraminidaza) seva a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cepiva - aktivna imunizacija proti podtipu h5n1 virusa influenca a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.